Home › Seattle Genetics and Takeda's cancer drug meets main trial goal
 

Keywords :   


Seattle Genetics and Takeda's cancer drug meets main trial goal

2014-09-29 19:14:26| Biotech - Topix.net

Seattle Genetics Inc and Takeda Pharmaceutical Co Ltd said their approved cancer drug was successfully used as a consolidation therapy in a late-stage trial for patients with a type of lymphatic cancer. Patients who received the drug, Adcetris, immediately after a stem cell transplant, lived significantly longer without the disease progressing than those who were given a placebo, the companies said in a joint statement.

Tags: main trial goal drug

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
08.07Boeing pleads guilty to a criminal fraud charge
08.07Hurricane Beryl Update Statement
08.07Summary for Hurricane Beryl (AT2/AL022024)
08.07Hurricane Beryl Potential Storm Surge Flooding Map
08.07Hurricane Beryl Probabilistic Storm Surge Graphics
08.07Hurricane Beryl Public Advisory Number 38
08.07Hurricane Beryl Storm Surge Watch/Warning Map
08.07Hurricane Beryl Graphics
More »